Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Q4 2025 Earnings Call Transcript February 26, 2026
Rhythm Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-0.73025, expectations were $-0.79.
Operator: Good day. Thank you for standing by. Welcome to the Rhythm Pharmaceuticals, Inc. fourth quarter and fiscal year 2025 earnings conference call. At this time, all participants are in a listen-only mode. After the speaker’s presentation, there will be a question-and-answer session....
